A Healthy Volunteer Study of PBI-4050
NCT04695041
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
65
Enrollment
INDUSTRY
Sponsor class
Conditions
Fibrosis
Inflammation
Interventions
DRUG:
PBI-4050/ Placebo
DRUG:
PBI-4050/ Placebo
DRUG:
PBI-4050/ Placebo
DRUG:
PBI-4050/ Placebo
DRUG:
PBI-4050/ Placebo
Sponsor
Liminal BioSciences Ltd.